Resources

Resources for the OmniaBio

Webinar Transcript: CAR-T Manufacturing Intensification: The Next Wave of CAR-T Commercialization

Since the commercialization of the first CAR-T cell therapies, these revolutionary treatments have reshaped the landscape of cancer therapy, offering unprecedented hope to patients with hematologic malignancies. In this webinar transcript, which was hosted on Cell & Gene Therapy Insights, experts discuss commercialization strategies and manufacturing technology in advancing CAR-T cell therapies to market.

Webinar Transcript: CAR-T Manufacturing Intensification: The Next Wave of CAR-T Commercialization Read More »

Unlocking Success in CAR-T Technology Transfer: From Challenges to Seamless Execution

As CAR-T cell therapies continue to lead innovation and revolutionize disease treatment, with several approved CAR-T cell therapies and many more advancing through the clinical pipeline, the significance of effective tech transfer is undeniable. In this webinar, learn from our speakers’ past experiences as they define the core principles of a successful CAR-T tech transfer and more.

Unlocking Success in CAR-T Technology Transfer: From Challenges to Seamless Execution Read More »

Webinar Transcript: iPSC-based Therapy Dilemmas Explored: Overcoming Hurdles for Future Success

As the number of iPSC-based therapies in clinical development is increasing, the industry is seeing significant advancement following decades of the industry’s iPSC development efforts. In this webinar transcript, which was hosted on Cell & Gene Therapy Insights in March 2024, industry experts delve into the critical aspects of reshaping the future landscape of iPSC-based therapies.

Webinar Transcript: iPSC-based Therapy Dilemmas Explored: Overcoming Hurdles for Future Success Read More »

Flexible, Cost-Effective Manufacturing of CD19- CAR-T Cells Using the G-Rex® System

This technical application poster, originally showcased at CAR-T CR 2023, shares data demonstrating OmniaBio’s flexible and cost-effective manufacturing platform that can be tailored to accommodate specific client needs. The poster shows the integration of the CliniMACS® Plus (Miltenyi Biotec) for T cell isolation, G-Rex® (Wilson Wolf Manufacturing) for T cell activation and expansion, followed by

Flexible, Cost-Effective Manufacturing of CD19- CAR-T Cells Using the G-Rex® System Read More »

Closed, Automated Manufacturing of CD19- CAR-T Cells Using Cocoon® Platform and Gibco™ CTS™ Rotea™ for Harvest

This technical application poster, originally showcased at CAR-T CR 2023, shares data demonstrating one of OmniaBio’s closed, automated CAR-T manufacturing platforms that can be tailored to accommodate specific client needs. This poster shows the integration of the CliniMACS® Plus System (Miltenyi Biotec) for T cell isolation, Cocoon® Platform (Lonza) for T cell activation, viral

Closed, Automated Manufacturing of CD19- CAR-T Cells Using Cocoon® Platform and Gibco™ CTS™ Rotea™ for Harvest Read More »